Brian Goff is Chief Executive Officer of Agios Pharmaceuticals, Inc. (AGIO). The company reported total compensation of $5,370,389 for fiscal year 2025.
| Salary | $846,864 |
|---|---|
| Bonus | — |
| Stock awards | $1,291,680 |
| Option awards | $2,627,252 |
| Non-equity incentive plan | $592,804 |
| Pension and non-qualified deferred compensation | — |
| All other compensation | $11,789 |
| Total | $5,370,389 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Agios Pharmaceuticals, Inc. filed April 24, 2026, accession 0001193125-26-177086.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $846,864 | — | $1,291,680 | $2,627,252 | $592,804 | — | $11,789 | $5,370,389 |
| FY2024 | Chief Executive Officer | $822,198 | — | $1,742,580 | $3,480,506 | $719,423 | — | $11,653 | $6,776,359 |
| FY2023 | Chief Executive Officer | $798,250 | — | $637,755 | $1,319,723 | $648,179 | — | $12,546 | $3,416,453 |
Totals as disclosed in each year's own compensation disclosure for Agios Pharmaceuticals, Inc..
| Peer-group chief executive median | $10,441,224 |
|---|---|
| Difference from that median | $-5,070,835 |
| Percentile within the disclosed peer group | 6th |
| Peers with a disclosed figure | 17 |
Medians and percentiles are computed across the peer group Agios Pharmaceuticals, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Brian Goff this page | Chief Executive Officer | $5,370,389 |
| Krishnan Viswanadhan | Chief Corporate Development & Strategy Officer | $2,805,026 |
| Cecilia Jones | Chief Financial Officer | $2,518,222 |
| James Burns | Chief Legal Officer | $2,369,416 |
| Sarah Gheuens | Chief Medical Officer, Head of Research & Development | $2,086,680 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Agios Pharmaceuticals, Inc. compensation brief.
Brian Goff's compensation sits inside Agios Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.